Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Nisoldipine

U.S. FDA Requirements: Nisoldipine

Pharmaceutical / Drug Definition : Suppresses calcium transport into vascular smooth muscle cells. This suppression inhibits vasoconstriction and dilates coronary arteries, improving myocardial oxygen uptake.

Registrar Corp assists Nisoldipine companies with:

  • FDA Registration Nisoldipine
  • FDA Listing Nisoldipine
  • FDA Label Requirements and Exceptions Nisoldipine
  • FDA Import Information Nisoldipine
  • FDA Detentions Nisoldipine (Nisoldipine Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Nisoldipine (Nisoldipine Suppliers)
       - Processors Nisoldipine
       - Repackers Nisoldipine
       - Relabelers Nisoldipine
       - Exporters Nisoldipine
       - Importers Nisoldipine
For more information about Nisoldipine, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco